Cargando…
PRAS40 promotes NF-κB transcriptional activity through association with p65
PRAS40 has been shown to have a crucial role in the repression of mammalian target of rapamycin (mTOR). Nonetheless, PRAS40 appears to have an oncogenic function in cancer cells. Whether PRAS40 mediates signaling independent of mTOR inhibition in cancer cells remains elusive. Here PRAS40 overexpress...
Autores principales: | Zhu, G, Qi, Q, Havel, J J, Li, Z, Du, Y, Zhang, X, Fu, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623906/ https://www.ncbi.nlm.nih.gov/pubmed/28945219 http://dx.doi.org/10.1038/oncsis.2017.80 |
Ejemplares similares
-
PRAS40 hyperexpression promotes hepatocarcinogenesis
por: Qi, Zhaolai, et al.
Publicado: (2020) -
PRAS40 signaling in tumor
por: Lv, Dan, et al.
Publicado: (2017) -
Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway
por: Havel, Jonathan J., et al.
Publicado: (2014) -
TIFA promotes colorectal cancer cell proliferation in an RSK‐ and PRAS40‐dependent manner
por: Shen, Wenzhi, et al.
Publicado: (2022) -
mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013)